- Presentations
- 2
- Markets
- 1
Columvi is a brand of Glofitamab marketed by Genentech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Glofitamab
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 10 mg/10 mL injection, 2.5 mg/2.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Columvi 10 mg/10 mL injectionIntravenous Cold chain | Genentech | US FDA | Available on request |
| Columvi 2.5 mg/2.5 mL injectionIntravenous Cold chain | Genentech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Columvi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.